What is a stock summary page? Click here for an overview.
Business Description
Quanterix Corp
NAICS : 334517
SIC : 3842
ISIN : US74766Q1013
Description
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.74 | |||||
| Equity-to-Asset | 0.81 | |||||
| Debt-to-Equity | 0.11 | |||||
| Debt-to-EBITDA | -0.84 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.52 | |||||
| Beneish M-Score | -2.32 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.5 | |||||
| 3-Year EBITDA Growth Rate | 7 | |||||
| 3-Year EPS without NRI Growth Rate | 13.4 | |||||
| 3-Year FCF Growth Rate | 16.1 | |||||
| 3-Year Book Growth Rate | -10.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 20.43 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 14.01 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.66 | |||||
| 9-Day RSI | 36.26 | |||||
| 14-Day RSI | 37.62 | |||||
| 3-1 Month Momentum % | -25 | |||||
| 6-1 Month Momentum % | -40 | |||||
| 12-1 Month Momentum % | -64.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.66 | |||||
| Quick Ratio | 7.88 | |||||
| Cash Ratio | 6.88 | |||||
| Days Inventory | 196.55 | |||||
| Days Sales Outstanding | 80.69 | |||||
| Days Payable | 39.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.6 | |||||
| Shareholder Yield % | 1.42 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.9 | |||||
| Operating Margin % | -38.85 | |||||
| Net Margin % | -28.45 | |||||
| FCF Margin % | -28.45 | |||||
| ROE % | -11.35 | |||||
| ROA % | -9.31 | |||||
| ROIC % | -53.03 | |||||
| 3-Year ROIIC % | 26.73 | |||||
| ROC (Joel Greenblatt) % | -74.58 | |||||
| ROCE % | -13.98 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2 | |||||
| PB Ratio | 0.82 | |||||
| Price-to-Tangible-Book | 0.83 | |||||
| EV-to-EBIT | -0.51 | |||||
| EV-to-Forward-EBIT | -0.51 | |||||
| EV-to-EBITDA | -0.61 | |||||
| EV-to-Revenue | 0.2 | |||||
| EV-to-Forward-Revenue | 0.19 | |||||
| EV-to-FCF | -0.7 | |||||
| Price-to-GF-Value | 0.38 | |||||
| Price-to-Net-Current-Asset-Value | 0.94 | |||||
| Price-to-Net-Cash | 1.27 | |||||
| Earnings Yield (Greenblatt) % | -196.08 | |||||
| FCF Yield % | -14.16 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:QTRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Quanterix Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 135.436 | ||
| EPS (TTM) ($) | -1 | ||
| Beta | 1.01 | ||
| 3-Year Sharpe Ratio | -0.55 | ||
| 3-Year Sortino Ratio | -0.71 | ||
| Volatility % | 39.67 | ||
| 14-Day RSI | 37.62 | ||
| 14-Day ATR ($) | 0.468273 | ||
| 20-Day SMA ($) | 7.3465 | ||
| 12-1 Month Momentum % | -64.89 | ||
| 52-Week Range ($) | 6.3 - 23.94 | ||
| Shares Outstanding (Mil) | 38.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Quanterix Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Quanterix Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Quanterix Corp Frequently Asked Questions
What is Quanterix Corp(QTRX)'s stock price today?
The current price of QTRX is $7.02. The 52 week high of QTRX is $23.94 and 52 week low is $6.30.
When is next earnings date of Quanterix Corp(QTRX)?
The next earnings date of Quanterix Corp(QTRX) is 2025-05-08 Est..
Does Quanterix Corp(QTRX) pay dividends? If so, how much?
Quanterix Corp(QTRX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers